| 1 |
14605878 | Basic science going clinical: molecularly targeted therapy of chronic myelogenous leukemia. | 2004 Feb |
1 |
| 2 |
14718589 | Imatinib-mesylate blocks recombinant T-type calcium channels expressed in human embryonic kidney-293 cells by a protein tyrosine kinase-independent mechanism. | 2004 Apr |
1 |
| 3 |
15094158 | Changing picture of cellular drug resistance in human leukemia. | 2004 Apr |
1 |
| 4 |
11342454 | Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha. | 2001 May 15 |
1 |
| 5 |
11409908 | Tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia: so far so good? | 2001 Jun |
1 |
| 6 |
11495816 | [Leukemogenesis and new therapy development: the example of chronic myelogenous leukemia]. | 2001 Jul |
2 |
| 7 |
10688835 | Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification. | 2000 Mar 1 |
1 |
| 8 |
9345054 | The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells. | 1997 Nov 1 |
2 |
| 9 |
9389713 | CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins. | 1997 Dec 15 |
1 |